Cingulate, Inc.

As of June 20, 2025, Cingulate, Inc. is in a mildly bearish trend, influenced by daily moving averages and monthly Bollinger Bands, despite some mildly bullish signals from the weekly MACD and KST.

Cingulate, Inc. is a micro-cap company in the Pharmaceuticals & Biotechnology industry, currently reporting a net profit loss of $4 million and a market cap of $18.89 million. Key metrics include a P/E ratio of NA, a dividend yield of 0.00%, and a return on equity of -276.12%.

As of Jun 18, Cingulate, Inc. has a market capitalization of 18.89 million, categorizing it as a Micro Cap company, with net sales of 0.00 million and a net profit of -16.37 million over the latest four quarters. As of Dec 24, the company reported shareholder's funds of 7.46 million and total assets of 14.86 million.